Access Ov Monitor Assay
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K031297, from Beckman Coulter, Inc. (Chaska, MN). Product code LTK, class 2.
As of Nov 20, 2026, K031297 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on May 2, 2003 after 8 days, with no recalls tied to it in FDA's recall database.
- Review time: 8 days
- Recalls: 0
The Access OV Monitor assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of CA 125 antigen levels in human serum and plasma, using the Access Immunoassay Systems. This device is indicated for use in the measurement of CA 125 antigen to aid in the management of ovarian cancer patients.
- Access Ov Monitor Immunoenzymetric AssayK023597 · Beckman Coulter, Inc. · Dec 11, 2002
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 24, 2003
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files